Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects
Michael J. Perley, David M. Kipnis
Michael J. Perley, David M. Kipnis
Published December 1, 1967
Citation Information: J Clin Invest. 1967;46(12):1954-1962. https://doi.org/10.1172/JCI105685.
View: Text | PDF
Research Article Article has an altmetric score of 1

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects

  • Text
  • PDF
Abstract

The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.

Authors

Michael J. Perley, David M. Kipnis

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1964 1957 Total
Citations: 1 8 8 6 16 15 12 13 12 25 20 10 21 16 17 45 14 26 28 23 14 11 9 5 6 2 9 3 5 6 2 7 5 6 6 5 3 8 8 14 9 7 13 10 8 15 10 17 9 5 11 7 13 13 17 18 15 4 1 1 673
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (673)

Title and authors Publication Year
Glucose-dependent insulinotropic polypeptide (GIP)
Müller TD, Adriaenssens A, Ahrén B, Blüher M, Birkenfeld AL, Campbell JE, Coghlan MP, D'Alessio D, Deacon CF, DelPrato S, Douros JD, Drucker DJ, Figueredo Burgos NS, Flatt PR, Finan B, Gimeno RE, Gribble FM, Hayes MR, Hölscher C, Holst JJ, Knerr PJ, Knop FK, Kusminski CM, Liskiewicz A, Mabilleau G, Mowery SA, Nauck MA, Novikoff A, Reimann F, Roberts AG, Rosenkilde MM, Samms RJ, Scherer PE, Seeley RJ, Sloop KW, Wolfrum C, Wootten D, DiMarchi RD, Tschöp MH
Molecular Metabolism 2025
A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding.
Lin H, Suzuki K, Smith N, Li X, Nalbach L, Fuentes S, Spigelman AF, Dai XQ, Bautista A, Ferdaoussi M, Aggarwal S, Pepper AR, Roma LP, Ampofo E, Li WH, MacDonald PE
Nature Communications 2024
Metabolic hormones are integral regulators of female reproductive health and function.
Athar F, Karmani M, Templeman NM
Bioscience Reports 2024
Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance.
Bergman RN
Journal of Clinical Investigation 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V
2024
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu QK
Frontiers in Endocrinology 2024
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff A, Müller TD
Physiology 2024
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD
Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP, Roshanravan B
Clinical Journal of the American Society of Nephrology : CJASN 2024
Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies
Bayanati M, Ismail Mahboubi Rabbani M, Sirous Kabiri S, Mir B, Rezaee E, Tabatabai SA
Iranian Journal of Pharmaceutical Research : IJPR 2024
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists
Umapathysivam MM, Araldi E, Hastoy B, Dawed AY, Vatandaslar H, Sengupta S, Kaufmann A, Thomsen S, Hartmann B, Jonsson AE, Kabakci H, Thaman S, Grarup N, Have CT, Færch K, Gjesing AP, Nawaz S, Cheeseman J, Neville MJ, Pedersen O, Walker M, Jennison C, Hattersley AT, Hansen T, Karpe F, Holst JJ, Jones AG, Ristow M, McCarthy MI, Pearson ER, Stoffel M, Gloyn AL
2023
Beta Cell Dysfunction in Youth- and Adult-Onset Type 2 Diabetes: An Extensive Narrative Review with a Special Focus on the Role of Nutrients
Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E
Nutrients 2023
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature.
Saini K, Sharma S, Khan Y
Frontiers in Molecular Biosciences 2023
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD.
Petrovic A, Igrec D, Rozac K, Bojanic K, Kuna L, Kolaric TO, Mihaljevic V, Sikora R, Smolic R, Glasnovic M, Wu GY, Smolic M
Current issues in molecular biology 2023
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods.
Aulinger BA, D'Alessio DA
American journal of physiology. Endocrinology and metabolism 2023
Impaired incretin homeostasis in non-diabetic moderate-severe CKD
Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP, Roshanravan B
2023
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L, Berra C, Fiorina P, Davalli A, La Rosa S, Perego C, Higgins PB
American journal of physiology. Endocrinology and metabolism 2023
An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect
Subramanian V, Bagger JI, Harihar V, Holst JJ, Knop FK, Villsbøll T
American journal of physiology. Endocrinology and metabolism 2023
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
K Rohli, C Boyer, S Blom, S Stephens
Biomolecules 2022
Role of the gut–brain axis in energy and glucose metabolism
H Wachsmuth, S Weninger, F Duca
Experimental & molecular medicine 2022
The Enteroendocrine System in Obesity.
Miedzybrodzka EL, Reimann F, Gribble FM
Handbook of experimental pharmacology 2022
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment.
Florentin M, Kostapanos MS, Papazafiropoulou AK
World journal of diabetes 2022
Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment.
Lok KH, Wareham NJ, Nair RS, How CW, Chuah LH
Pharmacological Research 2022
Chronic Kidney Disease is Associated With Attenuated Plasma Metabolome Response to Oral Glucose Tolerance Testing
Ahmadi A, Huda MN, Bennett BJ, Gamboa J, Zelnick LR, Smith LR, Chondronikola M, Raftery D, de Boer IH, Roshanravan B
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2022
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
E Grespan, T Giorgino, A Natali, E Ferrannini, A Mari
Metabolism 2021
New Aspects of Diabetes Research and Therapeutic Development
LS Satin, SA Soleimanpour, EM Walker, L Isom
Pharmacological reviews 2021
Non-glucose modulators of insulin secretion in healthy humans: (dis)similarities between islet and in vivo studies
JC Henquin
Metabolism 2021
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
N Mukherjee, L Lin, CJ Contreras, AT Templin
Metabolites 2021
The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
MA Nauck, DR Quast, J Wefers, AF Pfeiffer
Diabetes, obesity & metabolism 2021
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
L D'Marco, V Morillo, JL Gorriz, MK Suarez, M Nava, Á Ortega, H Parra, N Villasmil, J Rojas-Quintero, V Bermúdez, M Wallner
Journal of Diabetes Research 2021
miR-344-5p Modulates Cholesterol-Induced β-Cell Apoptosis and Dysfunction Through Regulating Caveolin-1 Expression
X Sun, G Ji, P Li, W Li, J Li, L Zhu
Frontiers in Endocrinology 2021
Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model
X Fang, Z Du, C Duan, S Zhan, T Wang, M Zhu, J Shi, J Meng, X Zhang, M Yang, Y Zuo
Life Sciences 2021
Regulation of Postabsorptive and Postprandial Glucose Metabolism by Insulin-Dependent and Insulin-Independent Mechanisms: An Integrative Approach
GD Dimitriadis, E Maratou, A Kountouri, M Board, V Lambadiari
Nutrients 2021
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
Y Zhang, C Han, W Zhu, G Yang, X Peng, S Mehta, J Zhang, L Chen, Y Liu
Cells 2021
The Role of Incretins on Insulin Function and Glucose Homeostasis
JJ Holst, LS Gasbjerg, MM Rosenkilde
Endocrinology 2021
A Century of Insulin: Outstanding Physiological Breakthroughs
A Matveyenko, G Sieck, A Klip
Physiology (Bethesda, Md.) 2021
A STUDY OF SERUM URIC ACID LEVELS IN TYPE 2 DIABETES MELLITUS CASES AND ITS COMPARISON WITH THE SERUM CREATININE LEVELS
S Shajahan, KS Lahari, P Kiranmai
2021
Management of Nutritional and Metabolic Complications of Bariatric Surgery
AG Bhasker, N Kantharia, S Baig, P Priya, M Lakdawala, MS Sancheti
2021
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
IJ Martins
2021
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment.
Pelle MC, Provenzano M, Zaffina I, Pujia R, Giofrè F, Lucà S, Andreucci M, Sciacqua A, Arturi F
2021
Development of innovative tools for investigation of nutrient-gut interaction
WK Huang, C Xie, RL Young, JB Zhao, H Ebendorff-Heidepriem, KL Jones, CK Rayner, TZ Wu
World journal of gastroenterology : WJG 2020
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
MA Nauck
Metabolism 2020
Acute Effects of Insulin on Cardiac Function in Patients with Diabetes Mellitus: Clinical Applicability and Feasibility
DD Naccache, S Yalonetsky, RB Yoseph
International Journal of Endocrinology 2020
Recent advances in understanding the role of glucagon-like peptide 1
J Reed, S Bain, V Kanamarlapudi
F1000Research 2020
An alternative pathway for sweet sensation: possible mechanisms and physiological relevance
E von Molitor, K Riedel, M Krohn, R Rudolf, M Hafner, T Cesetti
Pflügers Archiv - European Journal of Physiology 2020
Primary, Secondary, and Tertiary Effects of Carbohydrate Ingestion During Exercise
I Rollo, JT Gonzalez, CJ Fuchs, LJ van Loon, C Williams
Sports Medicine 2020
Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report
JN Corcoran, KJ Jacoby, TD Olives, SA Bangh, JB Cole
Journal of Medical Toxicology 2020
Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently‐diagnosed type 2 diabetes
TS Hannon, SL Edelstein, SA Arslanian, S Caprio, PS Zeitler, TA Buchanan, DA Ehrmann, KJ Mather, M Tripputi, SE Kahn, KJ Nadeau, DA Ehrmann, KA Temple, A Rue, E Barengolts, B Mokhlesi, EV Cauter, S Sam, MA Miller, SE Kahn, KM Atkinson, JP Palmer, KM Utzschneider, T Gebremedhin, A KernanSchloss, A Kozedub, BK Montgomery, EJ Morse, KJ Mather, T Garrett, TS Hannon, A Lteif, A Patel, R Chisholm, K Moore, V Pirics, L Pratt, KJ Nadeau, S Gross, PS Zeitler, J Williams, M CreeGreen, YG Reyes, K Vissat, SA Arslanian, K Brown, N Guerra, K Porter, S Caprio, M Savoye, B Pierpont, TA Buchanan, AH Xiang, E Trigo, E Beale, FN Hendee, N Katkhouda, K Nayak, M Martinez, C Montgomery, X Wang, SL Edelstein, JM Lachin, AH Tjaden, M Tripputi, LE ghormli, S Marcovina, J Harting, J Albers, D Hill, PJ Savage, EW Leschek
Pediatric Diabetes 2020
Surgical Metabolism: The Metabolic Care of the Surgical Patient
KA Davis, SH Rosenbaum
2020
The insulinotropic and incretin response to feeding a milk based protein matrix in healthy young women
M Amigo-Benavent, O Power-Grant, RJ FitzGerald, P Jakeman
Journal of Functional Foods 2020
The regulation of gastric ghrelin secretion
M NunezSalces, H Li, C FeinleBisset, RL Young, AJ Page
Acta physiologica (Oxford, England) 2020
Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
VB Chueire, E Muscelli
Archives of Endocrinology and Metabolism 2020
Measuring Insulin Resistance in Humans
VR Sharma, ST Matta, MW Haymond, ST Chung
Hormone Research in Pædiatrics 2020
Insulin sensitivity depends on the route of glucose administration
G Mingrone, S Panunzi, AD Gaetano, S Ahlin, V Spuntarelli, I Bondia-Pons, C Barbieri, E Capristo, A Gastaldelli, JJ Nolan
Diabetologia 2020
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
JI Mechanick, ME Farkouh, JD Newman, WT Garvey
Journal of the American College of Cardiology 2020
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, A Fritsche, F Gribble, HJ Grill, JF Habener, JJ Holst, W Langhans, JJ Meier, MA Nauck, D Perez-Tilve, A Pocai, F Reimann, DA Sandoval, TW Schwartz, RJ Seeley, K Stemmer, M Tang-Christensen, SC Woods, RD DiMarchi, MH Tschöp
Molecular Metabolism 2019
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
SP Schiellerup, K Skov-Jeppesen, JA Windeløv, MS Svane, JJ Holst, B Hartmann, MM Rosenkilde
Frontiers in Endocrinology 2019
The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
B Ahrén, Y Yamada, Y Seino
Journal of the Endocrine Society 2019
MicroRNA miR-7 Regulates Secretion of Insulin-Like Peptides
P Agbu, JJ Cassidy, J Braverman, A Jacobson, RW Carthew
Endocrinology 2019
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
JJ Holst
Frontiers in Endocrinology 2019
Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka
D Rathish, C Jayasumana, S Agampodi
Journal of Health, Population and Nutrition 2019
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
DK Mandaliya, S Seshadri
Pancreatology 2019
Incretin Physiology and Pharmacology in the Intensive Care Unit
MP Plummer, J Hermanides, AM Deane
Critical Care Clinics 2019
CA125 over‐release behavior following a 75‐g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer
Y He, Z Gu, Q Zhu, M Chen, C He, Y Huang, Q Li, W Di
International Journal of Cancer 2019
In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review
D Rathish, S Agampodi, C Jayasumana
Environmental Science and Pollution Research 2019
Effects of an 8-week community exercise program on health-related physical fitness in overweight and obese working adults
NA Roslan, AH Mokhtar
2019
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
M Mikov, N Pavlović, B Stanimirov, M Đanić, S Goločorbin-Kon, K Stankov, H Al-Salami
European Journal of Drug Metabolism and Pharmacokinetics 2019
What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?
J Ma, A Vella
Frontiers in Endocrinology 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
S Paternoster, M Falasca
Frontiers in Endocrinology 2018
Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects
K Ohashi, M Fujii, S Uda, H Kubota, H Komada, K Sakaguchi, W Ogawa, S Kuroda
npj Systems Biology and Applications 2018
The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
C Izzi-Engbeaya, AN Comninos, SA Clarke, A Jomard, L Yang, S Jones, A Abbara, S Narayanaswamy, PC Eng, D Papadopoulou, JK Prague, P Bech, IF Godsland, P Bassett, C Sands, S Camuzeaux, M Gomez-Romero, JT Pearce, MR Lewis, E Holmes, JK Nicholson, T Tan, R Ratnasabapathy, M Hu, G Carrat, L Piemonti, M Bugliani, P Marchetti, PR Johnson, SJ Hughes, AM Shapiro, GA Rutter, WS Dhillo
Diabetes, obesity & metabolism 2018
Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study
AD Koopman, F Rutters, SP Rauh, G Nijpels, JJ Holst, JW Beulens, M Alssema, JM Dekker, S Kaser
PloS one 2018
The Origin and Understanding of the Incretin Concept
JF Rehfeld
Frontiers in Endocrinology 2018
A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects
I Ikushima, L Jensen, A Flint, T Nishida, J Zacho, S Irie
Advances in Therapy 2018
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
JD Newman, AK Vani, JO Aleman, HS Weintraub, JS Berger, AZ Schwartzbard
Journal of the American College of Cardiology 2018
Differential GIP/GLP-1 intestinal cell distribution in diabetics’ yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length
AM Palha, SS Pereira, MM Costa, T Morais, AF Maia, M Guimarães, M Nora, MP Monteiro
Journal of Cellular Biochemistry 2018
A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka
D Rathish, I Senavirathna, C Jayasumana, S Agampodi, S Siribaddana
Environmental Science and Pollution Research 2018
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
F Bifari, R Manfrini, MD Cas, C Berra, M Siano, M Zuin, R Paroni, F Folli
Pharmacological research : the official journal of the Italian Pharmacological Society 2018
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6
S Adam, Y Liu, T Siahmansur, JH Ho, SS Dhage, R Yadav, JP New, R Donn, BJ Ammori, AA Syed, RA Malik, H Soran, PN Durrington
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2018
Glucagon Switches between GLP-1 and Glucagon Receptors in Normal and Hyperglycemic Mice
C Han, Y Zhang, W Zhu, G Yang, X Peng, S Mehta, J Zhang, Y Liu, L Chen
SSRN Electronic Journal 2018
Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients
O Taha, M Abdelaal, M Abozeid, A Askalany, M Alaa
Obesity Surgery 2017
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
DM Riddy, P Delerive, RJ Summers, PM Sexton, CJ Langmead, EL Barker
Pharmacological reviews 2017
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
MH Muskiet, L Tonneijck, MM Smits, MJ van Baar, MH Kramer, EJ Hoorn, JA Joles, DH van Raalte
Nature Reviews Nephrology 2017
The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a 13C breath test
K Kanoshima, M Matsuura, M Kaai, Y Inoh, K Ohkuma, H Iida, T Nonaka, K Fujita, T Ida, A Kusakabe, A Nakajima, M Inamori
Journal of Clinical Biochemistry and Nutrition 2017
A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
G Chikara, PK Sharma, P Dwivedi, J Charan, S Ambwani, S Singh
Indian Journal of Clinical Biochemistry 2017
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes
VA Gault
Diabetic Medicine 2017
Impact of Abdominal Subcutaneous Fat Reduction on Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus
AH Abdelhafez, O Taha, M Abdelaal, W Al-Najim, CW le Roux, NG Docherty
Bariatric Surgical Practice and Patient Care 2017
TEMPORARY REMOVAL: Rebirth of the Incretin Concept: Its conception and early development
V Marks
Peptides 2017
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
JA Lovshin
Canadian Journal of Diabetes 2017
Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature
FA Savignano, RO Crajoinas, BP Pacheco, LC Campos, MH Shimizu, AC Seguro, AC Girardi
European Journal of Pharmacology 2017
WITHDRAWN: Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
JA Lovshin
Canadian Journal of Diabetes 2017
A Machine Learning Approach to Detecting Sensor Data Modification Intrusions in WBANs
A Verner, D Butvinik
2017
The incretin hormone GLP-1 and mechanisms underlying its secretion: Hormone GLP-1 and its secretion
L Tian, T Jin
Journal of Diabetes 2016
The Macronutrients, Appetite, and Energy Intake
AL Carreiro, J Dhillon, S Gordon, KA Higgins, AG Jacobs, BM McArthur, BW Redan, RL Rivera, LR Schmidt, RD Mattes
Annual Review of Nutrition 2016
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
C Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, J Liao, MM Fletcher, D Yang, AJ Brown, C Zhou, J Deng, MW Wang
Pharmacological reviews 2016
Roles of the Gut in Glucose Homeostasis
JJ Holst, F Gribble, M Horowitz, CK Rayner
Diabetes care 2016
The biology of glucagon and the consequences of hyperglucagonemia
NJ Albrechtsen, RE Kuhre, J Pedersen, FK Knop, JJ Holst
Biomarkers in Medicine 2016
Bariatric surgery and obesity: influence on the incretins
B Laferrère
International Journal of Obesity Supplements 2016
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee
Endocrinology: Adult and Pediatric 2016
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
CF Shaefer
Clinical diabetes : a publication of the American Diabetes Association 2016
Interactions between kidney disease and diabetes: dangerous liaisons
R Pecoits-Filho, H Abensur, CC Betônico, AD Machado, EB Parente, M Queiroz, JE Salles, S Titan, S Vencio
Diabetology & metabolic syndrome 2016
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
BA Aulinger, TP Vahl, RL Prigeon, DA D'Alessio, DA Elder
American journal of physiology. Endocrinology and metabolism 2016
From organophosphate poisoning to diabetes mellitus: The incretin effect
D Rathish, SB Agampodi, MA Jayasumana, SH Siribaddana
Medical Hypotheses 2016
Albiglutide: Is a better hope against diabetes mellitus?
AK Sharma, PV Thanikachalam, SK Rajput
Biomedicine & Pharmacotherapy 2016
Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial
ST Azar, A Echtay, WM Bebakar, SA Araj, A Berrah, M Omar, A Mutha, K Tornøe, MS Kaltoft, N Shehadeh
Diabetes Obesity and Metabolism 2016
Cholesteryl Ester Transfer Protein (CETP) expression does not affect glucose homeostasis and insulin secretion: studies in human CETP transgenic mice
HF Raposo, EC Vanzela, JA Berti, HC Oliveira
Lipids in Health and Disease 2016
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
S Kalra, MP Baruah, RK Sahay, AG Unnikrishnan, S Uppal, O Adetunji
Indian journal of endocrinology and metabolism 2016
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
N Matikainen, E Björnson, S Söderlund, C Borén, B Eliasson, KH Pietiläinen, LH Bogl, A Hakkarainen, N Lundbom, A Rivellese, G Riccardi, JP Després, N Alméras, JJ Holst, CF Deacon, J Borén, MR Taskinen, K Maedler
PloS one 2016
Histoire des incrétines : Du chien brun au monstre de Gila
JL Schlienger
Médecine des Maladies Métaboliques 2016
Glucometabolic gut hormones: beyond the incretin effect
DP Sonne
Cardiovascular Endocrinology 2016
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider
Principles of Diabetes Mellitus 2016
Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance
PJ Lin, KT Borer, D Thompson
PloS one 2016
Incretin – based therapy in diabetes mellitus: present scenario and expanding horizons
SC Kohli
Nepal Journal of Epidemiology 2016
Endocrinology
C Napier, SH Pearce
Endocrinology 2016
Systems Pharmacology and Pharmacodynamics
DE Mager, HH Kimko
Systems Pharmacology and Pharmacodynamics 2016
Metabolic Syndrome and Diabetes
M Kurian, BM Wolfe, S Ikramuddin
2016
The Stress Response of Critical Illness: Metabolic and Hormonal Aspects
JC Preiser
2016
cAMP-independent effects of GLP-1 on β cells
Jelena Kolic, Patrick MacDonald
Journal of Clinical Investigation 2015
Stimulation of incretin secreting cells
R Pais, FM Gribble, F Reimann
Therapeutic Advances in Endocrinology and Metabolism 2015
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
N Irwin
World journal of diabetes 2015
Activation of Melatonin Signaling Promotes β-Cell Survival and Function
S Costes, M Boss, AP Thomas, AV Matveyenko
Molecular Endocrinology 2015
Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
A Myat, S Arri, DL Bhatt, BJ Gersh, SR Redwood, MS Marber
Cardiovascular Diabetology 2015
Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance
M Eriksen, DH Jensen, S Tribler, JJ Holst, S Madsbad, T Krarup
Diabetologia 2015
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
W Deng, S Qiu, G Yang, B Chen
Therapeutics and Clinical Risk Management 2015
Evolving Paradigms in the Nutritional Support of Critically Ill Surgical Patients
MD Rosenthal, EL Vanzant, RG Martindale, FA Moore
Current Problems in Surgery 2015
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition 2015
Detailed characterization of incretin cell distribution along the human small intestine
TP Guedes, S Martins, M Costa, SS Pereira, T Morais, A Santos, M Nora, M Monteiro
Surgery for Obesity and Related Diseases 2015
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, KE Kwok, RB Gopaluni, FK Knop
Medical & Biological Engineering & Computing 2015
The incretin effect in critically ill patients: a case–control study
ST Nielsen, S Janum, R Krogh-Madsen, TP Solomon, K Møller
Critical Care 2015
Linagliptin/metformin HCl (fixed combination therapy) for the treatment of Type 2 diabetes mellitus
A Bhargava
Expert Review of Endocrinology & Metabolism 2015
Chirurgie bariatrique et insulinosécrétion : Où en est-on ?
F Andreelli
Médecine des Maladies Métaboliques 2015
Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells
J Shuang, Y Zhang, L Ma, X Tan, J Huang, X Wang, G Xiong, Z Jiang, X Zhang, S Du, Y Gu, X Shi, Z Fan
Experimental and therapeutic medicine 2015
Technosphere Inhaled Insulin: Is Faster Better?
JL Leahy
Diabetes care 2015
Glucose metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after Biliopancreatic bypass surgery in the modification of Hess-Marceau the early stages of postoperative monitoring
II Dedov, EA Troshina, EV Ershova, YI Yashkov
Obesity and metabolism 2015
Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia models
Jiefei Bai, Shuang Zheng, Dongdong Jiang, Tingting Han, Yangxue Li, Yao Zhang, Wei Liu, Yunshan Cao, Yaomin Hu
International journal of clinical and experimental pathology 2015
Diet and Nutrition in Critical Care
D Youssef, K Amrein, C Schnedl, H Dobnig, AN Peiris
Diet and Nutrition in Critical Care 2015
Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging
BB Azad, V Rota, L Yu, R Mcgirr, AH Amant, TY Lee, S Dhanvantari, LG Luyt
Molecular imaging 2015
Small Intestinal Glucose Exposure Determines the Magnitude of the Incretin Effect in Health and Type 2 Diabetes
CS Marathe, CK Rayner, M Bound, H Checklin, S Standfield, J Wishart, K Lange, KL Jones, M Horowitz
Diabetes 2014
Short-Term Outcomes of Laparoscopic Single Anastomosis Gastric Bypass (LSAGB) for the Treatment of Type 2 Diabetes in Lower BMI (<30 kg/m2) Patients
MJ Kim, KY Hur
Obesity Surgery 2014
Incretins and the intensivist: what are they and what does an intensivist need to know about them?
MP Plummer, MJ Chapman, M Horowitz, AM Deane
Critical Care 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Effect of Insulin-Induced Hypoglycaemia on the Central Nervous System: Evidence from Experimental Studies
VF Jensen, IB Bøgh, J Lykkesfeldt
Journal of Neuroendocrinology 2014
MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
DP Sonne, M Hansen, FK Knop
European Journal of Endocrinology 2014
The neuro-incretin concept
B Ahrén
Regulatory Peptides 2014
Measurement of the Incretin Hormones: Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide
RE Kuhre, NJ Albrechtsen, B Hartmann, CF Deacon, JJ Holst
2014
Review: Surgical Treatment of Type 2 Diabetes
MD Gil, PP Alarcón, AL Ruiz, MÁ Ibañez, AH Torres, AB Cascales
Pharmacology & Pharmacy 2014
Network Identification of Hormonal Regulation
DJ Vis, JA Westerhuis, HC Hoefsloot, F Roelfsema, J der Greef, MM Hendriks, AK Smilde, P Holme
PloS one 2014
From gut changes to type 2 diabetes remission after gastric bypass surgeries
B Li, X Zhou, J Wu, H Zhou
Frontiers of Medicine 2013
A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction
JT Patterson, P Li, JW Day, VM Gelfanov, RD DiMarchi
Molecular Metabolism 2013
Cholesterol reduction ameliorates glucose-induced calcium handling and insulin secretion in islets from low-density lipoprotein receptor knockout mice
JC Souza, EC Vanzela, RA Ribeiro, LF Rezende, CA Oliveira, EM Carneiro, HC Oliveira, AC Boschero
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Mechanisms and Clinical Efficacy of Lixisenatide for the Management of Type 2 Diabetes
M Horowitz, CK Rayner, KL Jones
Advances in Therapy 2013
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
AI Duarte, E Candeias, SC Correia, RX Santos, C Carvalho, S Cardoso, A Plácido, MS Santos, CR Oliveira, PI Moreira
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Antidiabetic agents: past, present and future
A Mehanna
Future Medicinal Chemistry 2013
New Incretin Hormonal Therapies in Humans Relevant to Diabetic Cats
CE Reusch, I Padrutt
Veterinary Clinics of North America Small Animal Practice 2013
Once weekly exenatide: efficacy, tolerability and place in therapy
C Wysham, M Grimm, S Chen
Diabetes, Obesity and Metabolism 2013
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
MW Stolar, M Grimm, S Chen
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013
Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
AB Petersen, M Christensen
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013
Enteroendocrine hormone mimetics for the treatment of obesity and diabetes
N Irwin, PR Flatt
Current Opinion in Pharmacology 2013
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
CF Deacon, JJ Holst
Expert Opinion on Pharmacotherapy 2013
Paradoxical second-meal phenomenon in the acute post-exercise period
JT Gonzalez
Nutrition 2013
Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients
MJ Kim, HK Park, DW Byun, KI Suh, KY Hur
Asian Journal of Surgery 2013
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
C Hales, D Barker
International Journal of Epidemiology 2013
Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes
O Power, AB Nongonierma, P Jakeman, RJ FitzGerald
Proceedings of the Nutrition Society 2013
Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
BA Aulinger, A Bedorf, G Kutscherauer, J Heer, JJ Holst, B Goke, J Schirra
Diabetes 2013
Pleiotropic Effects of GLP-1. Cardiovascular Evidence of Effectiveness
PP Alarcón, AB Cascales, AL Ruiz, MÁ Gil, AH Torres, MD Gil
Pharmacology & Pharmacy 2013
Incretins: Player or Stayer?
AM Deane, M Horowitz
Journal of Intensive Care Medicine 2013
Glucose Metabolism in Critically Ill Patients: Are Incretins an Important Player?
ST Nielsen, R Krogh-Madsen, K Møller
Journal of Intensive Care Medicine 2013
Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways
M Nishizawa, H Nakabayashi, K Uehara, A Nakagawa, K Uchida, D Koya
American journal of physiology. Endocrinology and metabolism 2013
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
FS Willard, KW Sloop
Experimental Diabetes Research 2012
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes
DH Jensen, K Aaboe, JE Henriksen, A Vølund, JJ Holst, S Madsbad, T Krarup
Diabetologia 2012
Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
MA Khan, C Deaton, MK Rutter, L Neyses, MA Mamas
Heart Failure Reviews 2012
Incretin-based therapies
AH Stonehouse, T Darsow, DG Maggs
Journal of Diabetes 2012
Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion
H Zhang, J Li, X Liang, Y Luo, K Zen, CY Zhang
Journal of Molecular Endocrinology 2012
Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models
X Liu, L Zhang, Y Feng, L Zhang, H Qu, G Cao, Y Leng
Acta Pharmacologica Sinica 2012
Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice
L Ahlkvist, J Vikman, G Pacini, B Ahrén
Regulatory Peptides 2012
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors:
LK Golightly, CC Drayna, MT McDermott
Clinical Pharmacokinetics 2012
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
LK Golightly, CC Drayna, MT McDermott
Clinical Pharmacokinetics 2012
Elucidation of the function and role of cAMP sensor Epac2A in insulin secretion
T Shibasaki
Diabetology International 2012
Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice
C Chen, E Sibley
AJP Gastrointestinal and Liver Physiology 2012
Slowly and rapidly digestible starchy foods can elicit a similar glycemic response because of differential tissue glucose uptake in healthy men
C Eelderink, M Schepers, T Preston, RJ Vonk, L Oudhuis, MG Priebe
The American journal of clinical nutrition 2012
Doves, Diplomats, and Diabetes
M Watve
2012
Chronobiology and Obesity
M Garaulet, JM Ordovás
2012
Principles of Metabolic Surgery
WK Karcz, O Thomusch
2012
Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper
II Dedov, YI Yashkov, EV Ershova
Obesity and metabolism 2012
Inflammation of the Hypothalamus Leads to Defective Pancreatic Islet Function*
VC Calegari, AS Torsoni, EC Vanzela, EP Araújo, J Morari, CC Zoppi, L Sbragia, AC Boschero, LA Velloso
The Journal of biological chemistry 2011
Pancreatic β-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency
S Kavaler, H Morinaga, A Jih, WQ Fan, M Hedlund, A Varki, JJ Kim
The FASEB Journal 2011
Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice
C Chen, E Sibley
American journal of physiology. Gastrointestinal and liver physiology 2011
Metabolic Syndrome
M Wang
Metabolic Syndrome 2011
Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice
X Zhang, Z Wang, Y Huang, J Wang
Diabetes, Obesity and Metabolism 2011
Incrétines et nutrition entérale
D Quilliot, A Malgras, C Zallot, O Ziegler
Réanimation 2011
The potential of incretin-based therapies in type 1 diabetes
CS Suen, P Burn
Drug Discovery Today 2011
Blunted Insulinemia Using High Dialysate Glucose Concentration During Hemodialysis :
R Czabak-Garbacz, D Schneditz, E Zierler, E Eichmann, G Harter, H Hafner-Giessauf, B Obermayer-Pietsch
ASAIO Journal 2011
Nutrient detection by incretin hormone secreting cells
E Diakogiannaki, FM Gribble, F Reimann
Physiology & Behavior 2011
GLP-1 signaling and the regulation of pancreatic β-cells mass/function
J Buteau
Avances en Diabetología 2011
Control metabólico y pérdida de peso en pacientes con obesidad y diabetes mellitus tipo 2 tratados con exenatida
PP Alarcón, MD Gil, LM Román, MF Gómez, MV Zafra, JT Massó
Medicina Clínica 2011
Using Computer-aided Drug Design and Medicinal Chemistry Strategies in the Fight Against Diabetes
EP Semighini, JA Resende, P Andrade, PA Morais, I Carvalho, CA Taft, CH Silva
Journal of Biomolecular Structure and Dynamics 2011
The Expression and Function of Glucose-Dependent Insulinotropic Polypeptide in the Embryonic Mouse Pancreas
K Prasadan, M Koizumi, S Tulachan, C Shiota, N Lath, J Paredes, P Guo, Y El-Gohary, M Malek, S Shah, GK Gittes
Diabetes 2011
Disruption of Circadian Rhythms Accelerates Development of Diabetes through Pancreatic Beta-Cell Loss and Dysfunction
JE Gale, HI Cox, J Qian, GD Block, CS Colwell, AV Matveyenko
Journal of Biological Rhythms 2011
Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1
RO Crajoinas, FT Oricchio, TD Pessoa, BP Pacheco, LM Lessa, G Malnic, AC Girardi
American journal of physiology. Renal physiology 2011
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
A Lund, T Vilsbøll, JI Bagger, JJ Holst, FK Knop
American journal of physiology. Endocrinology and metabolism 2011
PWD/PhJ and WSB/EiJ Mice Are Resistant to Diet-Induced Obesity But Have Abnormal Insulin Secretion
KT Lee, S Karunakaran, MM Ho, SM Clee
Endocrinology 2011
An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells
Jeffrey Sturek, David Castle, Anthony Trace, Laura Page, Anna Castle, Carmella Evans-Molina, John Parks, Raghavendra Mirmira, Catherine Hedrick
Journal of Clinical Investigation 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
JS Dobrin, D Lebeche
Expert Review of Cardiovascular Therapy 2010
Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes
LR Brunham, JK Kruit, MR Hayden, CB Verchere
Current Diabetes Reports 2010
Add-on therapies to metformin for type 2 diabetes
M Shomali
Expert Opinion on Pharmacotherapy 2010
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
Brook's Clinical Pediatric Endocrinology
M Westwood
Brook's Clinical Pediatric Endocrinology 2010
Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice
JK Kruit, PH Kremer, L Dai, R Tang, P Ruddle, W Haan, LR Brunham, CB Verchere, MR Hayden
Diabetologia 2010
Exenatide and weight loss
DP Bradley, R Kulstad, DA Schoeller
Nutrition 2010
Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism
S Pannain, B Mokhlesi
Best Practice & Research Clinical Endocrinology & Metabolism 2010
Continuous Subcutaneous Insulin Infusion—An Historical Perspective
JS Skyler
Diabetes Technology & Therapeutics 2010
The use of exenatide in severely burned pediatric patients
GA Mecott, DN Herndon, GA Kulp, NC Brooks, AM Al-Mousawi, R Kraft, HG Rivero, FN Williams, LK Branski, MG Jeschke
Critical Care 2010
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes
M Salehi, B Aulinger, RL Prigeon, DA D'Alessio
Diabetes 2010
Bench-to-bedside review: The gut as an endocrine organ in the critically ill
A Deane, MJ Chapman, RJ Fraser, M Horowitz
Critical Care 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Textbook of Diabetes: Holt/Textbook of Diabetes
HE Larsson, AJ Delli, SA Ivarsson, Å Lernmark
Textbook of Diabetes: Holt/Textbook of Diabetes 2010
A Model for Glucose, Insulin, and Beta-Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
J Ribbing, B Hamrén, MK Svensson, MO Karlsson
The Journal of Clinical Pharmacology 2010
New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)
Z Yu, T Jin
Cellular Signalling 2010
Final Answer: Ghrelin Can Suppress Insulin Secretion in Humans, but Is It Clinically Relevant?
C Meyer
Diabetes 2010
HDL: More Than Just Cholesterol
A Meilina, A Wijaya
The Indonesian Biomedical Journal 2010
A Review of Exenatide in the Treatment of Type 2 Diabetes Mellitus
AG Samat, A Bhargava, V Reddy
Clinical medicine insights. Therapeutics 2010
Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
JL Leahy, IB Hirsch, KA Peterson, D Schneider
The Journal of clinical endocrinology and metabolism 2010
Recombinant Expression, in Vitro Refolding, and Biophysical Characterization of the Human Glucagon-like Peptide-1 Receptor
K Schröder-Tittmann, E Bosse-Doenecke, S Reedtz-Runge, C Ihling, A Sinz, K Tittmann, R Rudolph
Biochemistry 2010
Successful Versus Failed Adaptation to High-Fat Diet-Induced Insulin Resistance: The Role of IAPP-Induced  -Cell Endoplasmic Reticulum Stress
AV Matveyenko, T Gurlo, M Daval, AE Butler, PC Butler
Diabetes 2009
Insulin secretion in healthy subjects and patients with Type 2 diabetes – role of the gastrointestinal tract
J Ma, CK Rayner, KL Jones, M Horowitz
Best Practice & Research Clinical Endocrinology & Metabolism 2009
Surgical Approaches for the Prevention and Treatment of Type 2 Diabetes Mellitus
S Coffin, C Konduru, M Schwarcz, W Frishman
Cardiology in Review 2009
Roles of cAMP signalling in insulin granule exocytosis
S Seino, H Takahashi, W Fujimoto, T Shibasaki
Diabetes, Obesity and Metabolism 2009
The contribution of incretin hormones to the pathogenesis of type 2 diabetes
JJ Meier
Best Practice & Research Clinical Endocrinology & Metabolism 2009
Therapeutic potential for GIP receptor agonists and antagonists
N Irwin, PR Flatt
Best Practice & Research Clinical Endocrinology & Metabolism 2009
Targeting the Incretin System in Type 2 Diabetes Mellitus
M Potenza, EJ Rayfield
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2009
New treatments in type 2 diabetes: a focus on the incretin-based therapies
AH Barnett
Clinical Endocrinology 2009
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes
N Irwin, PL McClean, S Patterson, K Hunter, PR Flatt
Biological Chemistry 2009
Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
EJ Verspohl
Pharmacology & Therapeutics 2009
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
EZ Fisman, A Tenenbaum
Cardiovascular Diabetology 2009
Role and development of GLP-1 receptor agonists in the management of diabetes
CW Chia, JM Egan
Diabetes, metabolic syndrome and obesity : targets and therapy 2009
Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
S Brunton
Postgraduate Medicine 2009
Stimulation of incretin secretion by dietary lipid: is it dose dependent?
SM Yoder, Q Yang, TL Kindel, P Tso
AJP Gastrointestinal and Liver Physiology 2009
Cholesterol in islet dysfunction and type 2 diabetes
Liam R. Brunham, Janine K. Kruit, C. Bruce Verchere and Michael R. Hayden
Journal of Clinical Investigation 2008
Targeting β-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
M Salehi, BA Aulinger, DA D'Alessio
Endocrine reviews 2008
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
W Kim, JM Egan
Pharmacological reviews 2008
Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes
B Laferrère, J Teixeira, J McGinty, H Tran, JR Egger, A Colarusso, B Kovack, B Bawa, N Koshy, H Lee, K Yapp, B Olivan
The Journal of clinical endocrinology and metabolism 2008
Beta cell mass in diabetes: a realistic therapeutic target?
JJ Meier
Diabetologia 2008
Insulin increases excitability via a dose-dependent dual inhibition of voltage-activated K+currents in differentiated N1E-115 neuroblastoma cells
PA Lima, MI Vicente, FM Alves, JC Dionísio, PF Costa
European Journal of Neuroscience 2008
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
M Florentin, EN Liberopoulos, DP Mikhailidis, E MS
Expert Opinion on Pharmacotherapy 2008
DPP4 Inhibitors: a new approach in diabetes treatment
J Doupis, A Veves
Advances in Therapy 2008
Therapeutic Potential of Dipeptidyl Peptidase-IV Inhibitors in Patients With Diabetes Mellitus
KB Moore, CD Saudek
American Journal of Therapeutics 2008
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery
G Mingrone
Nutrition, Metabolism and Cardiovascular Diseases 2008
Protection of pancreatic beta-cells: Is it feasible?
E Bonora
Nutrition, Metabolism and Cardiovascular Diseases 2008
Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats
AV Matveyenko, JD Veldhuis, PC Butler
American journal of physiology. Endocrinology and metabolism 2008
β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
R Lupi, SD Prato
Diabetes & Metabolism 2008
Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes
C Gredal, A Rosenfalck, A Dejgaard, J Hilsted
Diabetes Research and Clinical Practice 2008
The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
J Girard
Diabetes & Metabolism 2008
GLP-1 et système nerveux : un mécanisme de son action antidiabétique
R Burcelin, M Massebœuf, C Cabou
Médecine des Maladies Métaboliques 2008
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
JH Wani, J John-Kalarickal, VA Fonseca
Cardiology Clinics 2008
GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis
K Toyoda, T Okitsu, S Yamane, T Uonaga, X Liu, N Harada, S Uemoto, Y Seino, N Inagaki
Biochemical and Biophysical Research Communications 2008
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
LF van Gaal, SW Gutkin, MA Nauck
European Journal of Endocrinology 2008
Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein
AV Matveyenko, JD Veldhuis, PC Butler
American journal of physiology. Endocrinology and metabolism 2008
Adaptation to intermittent stress promotes maintenance of β-cell compensation: comparison with food restriction
HE Bates, A Sirek, MA Kiraly, JT Yue, MC Riddell, SG Matthews, M Vranic
American journal of physiology. Endocrinology and metabolism 2008
Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats
AV Matveyenko, JD Veldhuis, PC Butler
American journal of physiology. Endocrinology and metabolism 2008
Beyond Glycemic Control
CL Martin
The Diabetes Educator 2008
Controversies in Treating Diabetes
D LeRoith, AI Vinik
2008
Type 2 Diabetes Mellitus
MN Feinglos, MA Bethel
2008
Pancreatic Beta Cell in Health and Disease
S Seino, GI Bell
2008
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight and energy expenditure
Tanya Hansotia, Adriano Maida, Grace Flock, Yuichiro Yamada, Katsushi Tsukiyama, Yutaka Seino, Daniel J Drucker
Journal of Clinical Investigation 2007
β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment
LR Brunham, JK Kruit, TD Pape, JM Timmins, AQ Reuwer, Z Vasanji, BJ Marsh, B Rodrigues, JD Johnson, JS Parks, CB Verchere, MR Hayden
Nature Medicine 2007
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
B Laferrère, S Heshka, K Wang, Y Khan, J McGinty, J Teixeira, AB Hart, B Olivan
Diabetes care 2007
Glucose-dependent insulinotropic polypeptide and its role in obesity
DH Song, MM Wolfe
Current Opinion in Endocrinology, Diabetes and Obesity 2007
Incretins and their role in the management of diabetes
JP Frias, SV Edelman
Current Opinion in Endocrinology, Diabetes and Obesity 2007
Incretin hormone mimetics and analogues in diabetes therapeutics
BD Green, PR Flatt
Best Practice & Research Clinical Endocrinology & Metabolism 2007
Efficacy and Safety of Mitiglinide in Korean Type 2 Diabetic Patients: Prospective Randomised Multicenter Comparative Phase III Study
SY Kim, HJ Kim, KA Han, SH Baek, HS Son, BS Cha, KW Min
The Journal of Korean Diabetes Association 2007
DPP-4 inhibitors as a new target of action for Type 2 diabetes mellitus: a focus on vildagliptin
V Fonseca, AD Rao
Expert Review of Endocrinology & Metabolism 2007
Metabolic Syndrome and Type 2 Diabetes: Can We Stop the Weight Gain with Diabetes?
D Joffe, RT Yanagisawa
Medical Clinics of North America 2007
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
LL Ilag, L Kerr, JK Malone, MH Tan
Clinical Therapeutics 2007
Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes
NM Munro, JC Levy
Primary Care Diabetes 2007
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes
R Donnelly
Diabetes, Obesity and Metabolism 2007
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
I Idris, R Donnelly
Diabetes, Obesity and Metabolism 2007
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies
A Barnett, J Allsworth, K Jameson, R Mann
Current Medical Research and Opinion 2007
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
JJ Meier, CF Deacon, WE Schmidt, JJ Holst, MA Nauck
Diabetologia 2007
Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes
D Maggs, I MacDonald, MA Nauck
Diabetes, Obesity and Metabolism 2007
A Mathematical Model of the Oral Glucose Tolerance Test Illustrating the Effects of the Incretins
PL Brubaker, EL Ohayon, LM D’Alessandro, KH Norwich
Annals of Biomedical Engineering 2007
Polycystic Ovary Syndrome
MA Brown, RJ Chang
Ultrasound Quarterly 2007
Early-phase insulin secretion is disturbed in obese subjects with glucose intolerance
A Mizuno, H Arai, M Fukaya, M Sato, YO Hisami, E Takeda, T Doi
Metabolism 2007
Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management
S Wild, C Byrne
Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management 2007
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
PM Jauslin, HE Silber, N Frey, R Gieschke, US Simonsson, K Jorga, MO Karlsson
The Journal of Clinical Pharmacology 2007
Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients
E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, JJ Holst, E Ferrannini
Diabetes 2007
Insulin Sensitivity as a Risk Factor for Common Carotid Intima Media Thickness (IMT): Its Relation to Atherosclerosis
SS Deo, SR Mahadik, AR Chogle, SL Soneji, CP Lulla
Clinical and Experimental Hypertension 2007
The Physiology of Glucagon-like Peptide 1
JJ Holst
Physiological reviews 2007
New drugs for the treatment of type 2 diabetes
TA Chowdhury, B Hossain
BRIT J HOSP MED 2007
Asthma and Hyperglycemia
S Chawla, D Seth, J Cortez, P Mahajan, D Kamat
Clinical Pediatrics 2007
Pharmacotherapy of Diabetes: New Developments
CE Mogensen
2007
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
JJ Meier, C F., WE Schmidt, JJ Holst, MA Nauck
Diabetologia 2007
 -Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes
AV Matveyenko, PC Butler
Diabetes 2006
GLP-1 et détection cérébrale du glucose, un relais de régulation de l’homéostasie glucidique
R Burcelin, PD Cani, C Knauf
médecine/sciences 2006
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank
2006
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank
2006
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank
2006
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level
C Alarcon, B Wicksteed, CJ Rhodes
Diabetologia 2006
Incretins and the development of type 2 diabetes
JJ Meier, MA Nauck
Current Diabetes Reports 2006
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus
C Triplitt, A Wright, E Chiquette
Pharmacotherapy 2006
Exenatide: A Novel Approach for Treatment of Type 2 Diabetes
N Mikhail
Southern Medical Journal 2006
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes
DM Kendall, D Kim, D Maggs
Diabetes Technology & Therapeutics 2006
Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus
C Triplitt, RA DeFronzo
Expert Review of Endocrinology & Metabolism 2006
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
CA Schnabel, M Wintle, O Kolterman
Vascular Health and Risk Management 2006
DPP-4 inhibitors and their potential role in the management of type 2 diabetes
A Barnett
International Journal of Clinical Practice 2006
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, HJ Woerle, B Göke
Gut 2006
Glycaemic management of type 2 diabetes
M Davies, B Srinivasan
Medicine 2006
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
T Adachi, T Tanaka, K Takemoto, T Koshimizu, A Hirasawa, G Tsujimoto
Biochemical and Biophysical Research Communications 2006
Chronic Pancreatitis: Recent Advances and Ongoing Challenges
SA Ahmad, CJ Wray, HR Rilo, KA Choe, A Gelrud, J Howington, AM Lowry, JB Matthews
Current Problems in Surgery 2006
Upper gastrointestinal function and glycemic control in diabetes mellitus
R Chaikomin, CK Rayner, KL Jones, M Horowitz
World journal of gastroenterology : WJG 2006
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Y Yamada, K Miyawaki, K Tsukiyama, N Harada, C Yamada, Y Seino
Diabetes 2006
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
MC Riddle, DJ Drucker
Diabetes care 2006
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen
D Ganten, K Ruckpaul, J Köhrle
2006
New Insights into Glucose Regulation
DF Kruger, CL Martin, CE Sadler
The Diabetes Educator 2006
Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
AM Mkrtumyan, EV Biryukova
Diabetes mellitus 2006
The incretins: a link between nutrients and well-being
R Burcelin
British Journal of Nutrition 2005
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
OA Roges, M Baron, A Philis-Tsimikas
Expert Opinion on Investigational Drugs 2005
Islet adaptation to insulin resistance: mechanisms and implications for intervention
B Ahren, G Pacini
Diabetes, Obesity and Metabolism 2005
Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetes
EM Sinclair, DJ Drucker
Current Opinion in Endocrinology & Diabetes 2005
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck
Diabetes/Metabolism Research and Reviews 2005
α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients
K Hücking, Z Kostic, C Pox, R Ritzel, JJ Holst, W Schmiegel, MA Nauck
Diabetic Medicine 2005
The GLP‐1 system as a therapeutic target
MC Edwards
Annals of Medicine 2005
Gastrointestinal Physiology
WC Orr
Principles and Practice of Sleep Medicine 2005
The [pre-] history of the incretin concept
W Creutzfeldt
Regulatory Peptides 2005
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker
Regulatory Peptides 2005
Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance
K Arii, K Ota, T Suehiro, Y Ikeda, K Nishimura, Y Kumon, K Hashimoto
Diabetes Research and Clinical Practice 2005
Pathogenesis of Type 2 Diabetes Mellitus
JL Leahy
Archives of Medical Research 2005
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
S Seino, T Shibasaki
Physiological reviews 2005
The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes
CA Schnabel
The British Journal of Diabetes & Vascular Disease 2005
Loss of beta cell function as fasting glucose increases in the non-diabetic range
IF Godsland, JA Jeffs, DG Johnston
Diabetologia 2004
Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism
G Dimitriadis, E Boutati, V Lambadiari, P Mitrou, E Maratou, P Brunel, SA Raptis
European Journal of Clinical Investigation 2004
Can we make surrogate β-cells better than the original?
GC Weir
Seminars in Cell & Developmental Biology 2004
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes
MA Nauck, A El-Ouaghlidi, B Gabrys, K Hücking, JJ Holst, CF Deacon, B Gallwitz, WE Schmidt, JJ Meier
Regulatory Peptides 2004
Factor analysis of the metabolic syndrome in spinal cord-injured men
LM Jones, M Legge, A Goulding
Metabolism 2004
Gastro-intestinal hormones GIP and GLP-1
TJ Kieffer
Annales d'Endocrinologie 2004
Incretins, insulin secretion and Type 2 diabetes mellitus
T Vilsbøll, JJ Holst
Diabetologia 2004
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
A Caumo, L Luzi
American journal of physiology. Endocrinology and metabolism 2004
Avaliação dietética de amidos pelas respostas glicêmica e insulinêmica em cães
GB Silveira, BP Paule, EP Socorro
ARQ BRAS MED VET ZOO 2004
Splanchnic bed metabolism of glucose in preterm neonates
SR van der Schoor, B Stoll, DL Wattimena, HA Büller, D Tibboel, DG Burrin, JB van Goudoever
The American journal of clinical nutrition 2004
Dipeptidyl Aminopeptidases in Health and Disease
N Back, IR Cohen, D Kritchevsky, A Lajtha, R Paoletti
2004
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini
International Textbook of Diabetes Mellitus 2003
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
VA Gault, FP O’Harte, PR Flatt
Neuropeptides 2003
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus
JE Gerich
Mayo Clinic Proceedings 2003
Hepatic glucose metabolism in humans—its role in health and disease
M Roden, E Bernroider
Best Practice & Research Clinical Endocrinology & Metabolism 2003
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
A Gastaldelli, E Ferrannini, Y Miyazaki, M Matsuda, RA DeFronzo,
Diabetologia 2003
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
SE Kahn
Diabetologia 2003
Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect
RL Prigeon, S Quddusi, B Paty, DA D'Alessio
American journal of physiology. Endocrinology and metabolism 2003
Engineering physiologically regulated insulin secretion in non-β cells by expressing glucagon-like peptide 1 receptor
L Wu, W Nicholson, CY Wu, M Xu, A McGaha, M Shiota, AC Powers
Gene Therapy 2003
Effect of Motilin on Endogenous Release of Insulin in Conscious Dogs in the Fed State
H Suzuki, H Kuwano, E Mochiki, N Haga, T Shimura, K Nomoto, T Tanaka, A Mizumoto, Z Itoh
Digestive Diseases and Sciences 2003
Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus normoglycemic rats
I Briaud, CL Kelpe, LM Johnson, PO Tran, V Poitout
Diabetes 2002
Insulin analogues: New therapies for type 2 diabetes mellitus
MA Bethel, MN Feinglos
Current Diabetes Reports 2002
The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes
RN Bergman, DT Finegood, SE Kahn
European Journal of Clinical Investigation 2002
Das Inkretinhormon GLP-1: Eine therapeutische Option bei Typ-2-Diabetes?
B Göke, B Hoppe, A Konrad, J Schirra
Pharmazie in unserer Zeit 2002
Insulin Therapy
R Ritzel, P Butler
Insulin Therapy 2002
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis
J Radziuk, S Pye
Diabetes/Metabolism Research and Reviews 2001
Incretin hormones - an update
JJ Ørskov
Scandinavian Journal of Clinical & Laboratory Investigation 2001
Metabolic handling of intraduodenal vs. intravenous glucose in humans
F Féry, J Devière, EO Balasse
American journal of physiology. Endocrinology and metabolism 2001
Obesity, Body Fat Distribution, Insulin Sensitivity and Islet β-Cell Function as Explanations for Metabolic Diversity
SE Kahn, RL Prigeon, RS Schwartz, WY Fujimoto, RH Knopp, JD Brunzell, D Porte
The Journal of nutrition 2001
Genetics of Diabetes Mellitus
WL Lowe
2001
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
SE Kahn
The Journal of clinical endocrinology and metabolism 2001
Streptozotocin and Alloxan in Experimental Diabetes. Comparison of the Two Models in Rats
S Islas-Andrade, MC Monsalve, JE de la Peña, AC Polanco, MA Palomino, AF Velasco
ACTA HISTOCHEMICA ET CYTOCHEMICA 2000
Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels
N SAKAMOTO, T NISHIIKE, H IGUCHI, K SAKAMOTO
Clinical Nutrition 2000
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+signalling and insulin secretion due to blockade of L-type Ca2+channels in rat islet β-cells
T Yada, M Nakata, T Shiraishi, M Kakei
British Journal of Pharmacology 1999
GIF biology and fat metabolism
RG Yip, MM Wolfe
Life Sciences 1999
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
M Shiomi, T Ito, T Tsukada, Y Tsujita, H Horikoshi
Atherosclerosis 1999
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
M Hiroyoshi, K Tateishi, Y Yasunami, K Maeshiro, J Ono, Y Matsuoka, S Ikeda
The American Journal of Gastroenterology 1999
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe, K Tsuda, H Hashimoto, T Yamashita, T Jomori, F Tashiro, J Miyazaki, Y Seino
Proceedings of the National Academy of Sciences 1999
JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats
T Ohta, N Furukawa, F Yonemori, K Wakitani
European Journal of Pharmacology 1999
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe, K Tsuda, H Hashimoto, T Yamashita, T Jomori, F Tashiro, J Miyazaki, Y Seino
Proceedings of the National Academy of Sciences 1999
Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats
HJ Kissler, H Gepp, A Schmiedl, PO Schwille
Metabolism 1999
The Glucagon-Like Peptides
TJ Kieffer, JF Habener
Endocrine reviews 1999
Implications of blood glucose, insulin resistance and β-cell function in impaired glucose tolerance
B Göke
Diabetes Research and Clinical Practice 1998
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
JE Gerich
Endocrine reviews 1998
Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose
AB Damholt, AM Buchan, H Kofod
Endocrinology 1998
Quantification of the effects of troglitazone on insulin sensitivity and β-cell function in Watanabe heritable hyperlipidemic rabbits: A minimal model analysis
B Zhang, K Saku, K Arakawa
Metabolism 1997
Incretin hormone expression in the gut of diabetic mice and rats
P Berghöfer, RG Peterson, K Schneider, HC Fehmann, B Göke
Metabolism 1997
7 Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus
DA Ehrmann
Baillière's Clinical Obstetrics and Gynaecology 1997
Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
O Schmitz, N Porksen, B Nyholm, C Skjaerbaek, PC Butler, JD Veldhuis, SM Pincus
American journal of physiology. Endocrinology and metabolism 1997
Clinical Research in Diabetes and Obesity
B Draznin, R Rizza
1997
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons
DA D'Alessio, R Vogel, R Prigeon, E Laschansky, D Koerker, J Eng, JW Ensinck
Journal of Clinical Investigation 1996
AN INTEGRATED VIEW OF β-CELL DYSFUNCTION IN TYPE-II DIABETES
VP Ph.D, RP M.D
Annual Review of Medicine 1996
Insulin-Stimulated Glucose Disposal: Does Adipose Play a Role?
SC Frost
Nutrition Reviews 1996
Vergleich pyloruserhaltende Whippel-Operation mit duodenumerhaltender Pankreaskopfresektion
MW Büchler, D Lübke, MW Müller, H Friess
European Surgery 1996
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathway
HC Fehmann, J Schweinfurth, J Jiang, B Göke
Research in Experimental Medicine 1996
Glucagon III
PJ Lefèbvre
1996
The relationship between insulin resistance and insulin secretion in japanese subjects with borderline glucose intolerance
T Wasada
Diabetes Research and Clinical Practice 1995
NIDDM in the Cat: Treatment with the Oral Hypoglycemic Medication, Glipizide
SL Ford
Veterinary Clinics of North America Small Animal Practice 1995
Intestinal effects of α-glucosidase inhibitors: absorption of nutrients and enterohormonal changes
B Göke, C Herrmann, R Göke, HC Fehmann, P Berghöfer, G Richter, R Arnold
European Journal of Clinical Investigation 1994
A glimpse of the ‘natural history’ of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis
PA Coates, RL Ollerton, SD Luzio, I Ismail, DR Owens
Diabetes Research and Clinical Practice 1994
Hyperinsulinemia in glucose intolerance: Is it true?
D Giugliano, A Quatraro, R Acampora, ND Rosa, A Ceriello, F D’Onofrio
Journal of Endocrinological Investigation 1994
Aberrant Function and Long-Term Survival of Mouse β Cells Exposed In Vitro to High Glucose Concentrations
M Pehuet-Figoni, E Ballot, JF Bach, L Chatenoud
Cell Transplantation 1994
Molecular Biology of Diabetes
B Draznin, D LeRoith
1994
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
D Pipeleers, R Kiekens, Z Ling, A Wilikens, F Schuit
Diabetologia 1994
Hyperinsulinemia in glucose intolerance: Is it true?
D Giugliano, A Quatraro, R Acampora, ND Rosa, A Ceriello, F DOnofrio
Journal of Endocrinological Investigation 1994
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
MA Nauck, MM Heimesaat, C Orskov, JJ Holst, R Ebert, W Creutzfeldt
Journal of Clinical Investigation 1993
Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus
PJ Randle
Diabetologia 1993
Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM)
S Efendic, CG Östenson
Journal of Internal Medicine 1993
Glucokinase activity in isolated islets from obese fa/fa Zucker rats
CB Chan
Biochemical Journal 1993
Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients
J Dupré, MT Behme, IM Hramiak, CJ Longo
Metabolism 1993
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
CN Hales, DJ Barker
Diabetologia 1992
Gut hormones and diabetes mellitus
W Creutzfeldt, M Nauck
Diabetes / Metabolism Reviews 1992
Type II Diabetes: Search for Primary Defects
R Turner, A Hattersley, J Cook
Annals of Medicine 1992
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
HC Fehmann, R Göke, B Göke
Molecular and Cellular Endocrinology 1992
Beta-cell secretory defect caused by mutations in glucokinase gene
R Page, A Hattersley, R Turner, G Velho, K Clément, ME Pueyo, P Froguel
The Lancet 1992
Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
A Mitrakou, D Kelley, M Mokan, T Veneman, T Pangburn, J Reilly, J Gerich
New England Journal of Medicine 1992
Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis
YT Kruszynska, PD Home, N McIntyre
Hepatology 1991
In vitro stimulation of glucose utilization by insulin in primary cultures of rat hepatocytes
M Suzuki, H Kojima, T Nakano, A Kashiwagi, H Hidaka, K Kosugi, Y Shigeta, Y Harano
Diabetes Research and Clinical Practice 1991
Hepatic sensitivity to insulin: Effects of sulfonylurea drugs
SD Prato, SV de Kreutzenberg, A Riccio, A Tiengo
The American Journal of Medicine 1991
Proceedings of the 1990 Laurentian Hormone Conference
AE Boyd, L Aguilar-Bryan, J Bryan, DL Kunze, L Moss, DA Nelson, AS Rajan, H Raef, H Xiang, GC Yaney
Proceedings of the 1990 Laurentian Hormone Conference 1991
The Liver and Glycogen Metabolism
J Radziuk
JPEN. Journal of parenteral and enteral nutrition 1991
Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level
JL Leahy, GC Weir
Diabetologia 1991
Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM
K Ratheiser, W Reitgruber, M Komjati, P Bratusch-Marrain, H Vierhapper, WK Waldhäusl
Acta Diabetologica Latina 1990
The Metabolic Associations of Intravenous Glucose Tolerance in the 10 Years from Diagnosis of Type 2 Diabetes
SW Coppack, CS Yajnik, HA Doll, V Thursfield, TD Hockaday
Diabetic Medicine 1990
An Unbiased Glucose Clamp Method Using a Variable Insulin Infusion: Its Application in Diabetic Adolescents
DR Matthews, JA Edge, DB Dunger
Diabetic Medicine 1990
Insulin release and peripheral sensitivity at the oral glucose tolerance test
J Cederholm, L Wibell
Diabetes Research and Clinical Practice 1990
Impaired glucose tolerance and diabetes in obesity: A 6-year follow-up study of glucose metabolism
D Jallut, A Golay, R Munger, P Frascarolo, Y Schutz, E Jéquier, JP Felber
Metabolism 1990
The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man
PH Groop
Scandinavian Journal of Clinical & Laboratory Investigation 1989
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
RA DeFronzo, E Ferrannini, DC Simonson
Metabolism 1989
Oral Hypoglycemic Agents
JA Oates, AJ Wood, JE Gerich
New England Journal of Medicine 1989
Suppression of Insulin Secretion by Falling Plasma Glucose Levels is Impaired in Type 2 Diabetes
JP Hosker, MA Burnett, DR Matthews, RC Turner
Diabetic Medicine 1988
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus
A Golay, JP Felber, E Jequier, RA DeFronzo, E Ferrannini
Diabetes / Metabolism Reviews 1988
Secretion uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release
H Kofod, JJ Holst, Å Lernmark
Regulatory Peptides 1988
2 Role of insulin resistance in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus
JE Gerich
Baillière's Clinical Endocrinology and Metabolism 1988
Potential Incretins
LT Shuster, VL Go, RA Rizza, PC O'brien, FJ Service
Mayo Clinic Proceedings 1988
5 Enteroinsular axis
JC Brown
Baillière's Clinical Endocrinology and Metabolism 1988
3 Pathogenesis of NIDDM—a disease of deficient insulin secretion
RC Turner, DR Matthews, A Clark, S O'Rahilly, AS Rudenski, J Levy
Baillière's Clinical Endocrinology and Metabolism 1988
The Pathology of the Endocrine Pancreas in Diabetes
PJ Lefèbvre, DG Pipeleers
1988
Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes
JF Caro, MK Sinha, SM Raju, O Ittoop, WJ Pories, EG Flickinger, D Meelheim, GL Dohm
Journal of Clinical Investigation 1987
Plasma amino acid values and pancreatic β-cell function in phenylketonuria
I Antonozzi, C Carducci, L Vestri, V Manzari, R Dominici
Journal of Inherited Metabolic Disease 1987
Gastrointestinal peptides and insulin secretion
R Ebert, W Creutzfeldt
Diabetes / Metabolism Reviews 1987
Tracer methods and the metabolic disposal of a carbohydrate load in man
J Radziuk
Diabetes / Metabolism Reviews 1987
Regulation of hepatic glucose metabolism in humans
RA DeFronzo, E Ferrannini
Diabetes / Metabolism Reviews 1987
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener
Proceedings of the National Academy of Sciences 1987
Metabolic factors in the insulin resistance in human obesity
M Meylan, C Henny, E Temler, E Jéquier, JP Felber
Metabolism 1987
7 Indirect calorimetry
E Jéquier, JP Felber
Baillière's Clinical Endocrinology and Metabolism 1987
Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity
JF Caro, O Ittoop, WJ Pories, D Meelheim, EG Flickinger, F Thomas, M Jenquin, JF Silverman, PG Khazanie, MK Sinha
Journal of Clinical Investigation 1986
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
M Nauck, F Stöckmann, R Ebert, W Creutzfeldt
Diabetologia 1986
Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus
WK Ward, JC Beard, D Porte
Diabetes / Metabolism Reviews 1986
Heterogeneity of insulin secretion in type II diabetes
SS Fajans
Diabetes / Metabolism Reviews 1986
α-GLUCOSIDASE INHIBITION IN OBESITY
T William-Olsson
Acta Medica Scandinavica 1986
Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge
P Calhoun, KS Brown, DA Krusch, E Barido, AH Farris, WG 3rd, LE Rudolf, DK Andersen, JB Hanks
Annals of Surgery 1986
Long term postnatal development of insulin secretion in early premature infants
RA King, RM Smith, GW Dahlenburg
Early Human Development 1986
Effect of a Purified Amylase Inhibitor on Carbohydrate Tolerance in Normal Subjects and Patients With Diabetes Mellitus
P Layer, RA Rizza, AR Zinsmeister, GL Carlson, EU DiMAGNO
Mayo Clinic Proceedings 1986
Gastric inhibitory polypeptide and insulin response to increasing doses of oral glucose: Dependency on glucose amount and volume of the test drink
S Schleser, R Ebert, W Creutzfeldt
Metabolism 1986
Metabolic abnormalities in children of non-insulin dependent diabetics
RD Leslie, HP Volkmann, M Poncher, I Hanning, H Orskov, KG Alberti
British medical journal (Clinical research ed.) 1986
Pathogenesis and Treatment of Diabetes Mellitus
JK Radder, HH Lemkes, HM Krans
1986
Clinical Endocrinology
A Labhart
Clinical Endocrinology 1986
Frontiers in Peritoneal Dialysis
JF Maher, JF Winchester
1986
Metabolic abnormalities in children of non-insulin dependent diabetics.
O'Rahilly SP, Matthews DR, Hosker JP, Turner RC
BMJ 1986
Effects of Previous Intake of Glucose on Postprandial Hyperglycemia in Type 2 Diabetics
V Grill, U Adamson, M Viklund
Acta Medica Scandinavica 1985
BETA BLOCKERS, BLOOD SUGARS, AND THIAZIDES
I Gove, MJ Kendall, S O'Rahilly
The Lancet 1985
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog
EJ Barrett, E Ferrannini, R Gusberg, S Bevilacqua, RA DeFronzo
Metabolism 1985
Glucose infused through the portal vein enhances liver gluconeogenesis and glycogenesis from [3-14C]pyruvate in the starved rat
M Soley, R Chieri, M Llobera, E Herrera
International Journal of Biochemistry 1985
A la recherche du temps perdu — epilogue to the Minkowski award lecture 1974
E Cerasi
Diabetologia 1985
New developments in the incretin concept
W Creutzfeldt, R Ebert
Diabetologia 1985
Effect of Intravenously Infused Porcine Gip on Serum Insulin in Obese and Lean Subjects Studied with the Hyperglycemic Clamp Technique
PF Amland, R Jorde, P Burhol, KE Giercksky
Scandinavian Journal of Gastroenterology 1985
Age and the Endocrine System
RH Noth, EL Mazzaferri
Clinics in Geriatric Medicine 1985
Comparison of Type I and Type II Diabetes
M Vranic, CH Hollenberg, G Steiner
1985
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes
RR Revers, R Fink, J Griffin, JM Olefsky, OG Kolterman
Journal of Clinical Investigation 1984
Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroen
GB Bolli, E Tsalikian, MW Haymond, PE Cryer, JE Gerich
Journal of Clinical Investigation 1984
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy
G Pehling, P Tessari, JE Gerich, MW Haymond, FJ Service, RA Rizza
Journal of Clinical Investigation 1984
The relative contribution of the nervous system, hormones, and metabolites to the total insulin response during a meal in the rat
HR Berthoud
Metabolism 1984
Metabolic effects of oral glucose in the liver of fasted rats
CB Niewoehner, DP Gilboe, FQ Nuttall
American journal of physiology. Endocrinology and metabolism 1984
Gastroentero-Pancreatic Hormones in Pregnancy
PJ Hornnes
Scandinavian Journal of Gastroenterology 1984
Mechanisms of Gastrointestinal Motility and Secretion
A Bennett, G Velo
1984
Evidence for restoration of hepatic glucose processing in type I diabetes mellitus
TT Aoki, FV Vlachokosta, MC Foss, MT Meistas
Journal of Clinical Investigation 1983
The 75-g oral glucose tolerance test: Effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man
WK Waldhäusl, S Gasić, P Bratusch-Marrain, P Nowotny
Diabetologia 1983
Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man
DL Sarson, PG Kopelman, HS Besterman, TR Pilkington, SR Bloom
Diabetologia 1983
The expanding clinical use of C-peptide radioimmunoassay
M Rendell
Acta Diabetologica Latina 1983
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
RA Defronzo, E Ferrannini, V Koivisto
The American Journal of Medicine 1983
Extrapancreatic effects of sulfonylureas
DH Lockwood, BL Maloff, SM Nowak, ML McCaleb
The American Journal of Medicine 1983
Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus
DH Lockwood, JM Amatruda
The American Journal of Medicine 1983
Role of environmental factors in the development of noninsulin-dependent diabetes mellitus
ES Horton
The American Journal of Medicine 1983
Roles of site and timing of the morning insulin injection in type 1 diabetes
MF Witt, NH White, JV Santiago
The Journal of Pediatrics 1983
Islet-Cell Antibodies and Beta-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus
S Srikanta, OP Ganda, GS Eisenbarth, JS Soeldner
New England Journal of Medicine 1983
Secretion and Hepatic Extraction of Insulin in Nondiabetic, Obese, Aged Subjects
E Bonora, C Coscelli, U Butturini
Journal of the American Geriatrics Society 1983
GIP and Insulin Responses to a Test Meal in Healthy and Obese Subjects
R Jorde, PF Amland, PG Burhol, KE Giercksky, R Ebert
Scandinavian Journal of Gastroenterology 1983
Postprandial hypoglycemia after Nissen fundoplication for reflux esophagitis
GP Zaloga, B Chernow
Gastroenterology 1983
Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus
W Waldhäusl, P Bratusch-Marrain, S Gasić, A Korn, P Nowotny
Diabetologia 1982
Clinical aspects of GIP secretion
B Beck, C Villaume, G Debry
Acta Diabetologica Latina 1982
Familial partial lipodystrophy: Complications of obesity in the non-obese?
DC Robbins, ES Horton, O Tulp, EA Sims
Metabolism 1982
Relationship between glucose oxidation and glucose tolerance in man
J Rousselle, A Bückert, P Pahud, E Jéquier, JP Felber
Metabolism 1982
Increased binding of insulin to mononuclear blood cells following gastric bypass for morbid obesity
JL Kramer, JD Halverson, L Thomas, JV Santiago
Journal of Surgical Research 1982
The Role of Carbohydrates in Appetite, Hunger and Obesity
PJ Geiselman, D Novin
Appetite 1982
Insulin secretory response to oral glucose load, diabetic microangiopathy and diabetic control: A study in non-insulin dependent diabetics
F Maneschi, J Cassar, C Lowy, EM Kohner
Metabolism 1982
The effect of hyperglycemia, hyperinsulinemia, and route of glucose administration on glucose oxidation and glucose storage
E Jacot, RA Defronzo, E Jéquier, E Maeder, JP Felber
Metabolism 1982
Effect of various oral glucose doses on plasma neutral amino acid levels
RM Pan, C Mauron, B Glaeser, RJ Wurtman
Metabolism 1982
Classification and Diagnosis of Diabetes Mellitus
S Genuth
Medical Clinics of North America 1982
Mechanisms of insulin resistance in man
RA Rizza, LJ Mandarino, JE Gerich
The American Journal of Medicine 1981
Effect of a 3-day fast on glucose storage and oxidation in obese hyperinsulinemic diabetics
JP Felber, HU Meyer, B Curchod, E Maeder, P Pahud, E Jéquier
Metabolism 1981
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
JP Felber, HU Meyer, B Curchod, HU Iselin, J Rousselle, E Maeder, P Pahud, E Jéquier
Diabetologia 1981
Exacerbation of Diabetes Mellitus by Antibodies to Exogenous Insulin
M Rendell, RG Hamilton, HM Drew, NF Adkinson
The American Journal of the Medical Sciences 1981
Enteral Nutritional Therapy
JL Rombeau, LR Barot
Surgical Clinics of North America 1981
Dose-response characteristics for effects of insulin on production and utilization of glucose in man
RA Rizza, LJ Mandarino, JE Gerich
American journal of physiology. Endocrinology and metabolism 1981
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
, HU Meyer, B Curchod, HU Iselin, J Rousselle, E Maeder, P Pahud, E Jéquier
Diabetologia 1981
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity
RJ Mahler
Acta Diabetologica 1981
Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes
JV Santiago, NH White
Annals of Biomedical Engineering 1980
Carbohydrate Homeostasis and the Liver
J Wahren
Acta Medica Scandinavica 1980
DEVELOPMENTAL ASPECTS OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) AND ITS POSSIBLE ROLE IN THE ENTEROINSULAR AXIS IN NEONATES
A Lucas, DL Sarson, SR Bloom, A Aynsley-Green
Acta Paediatrica 1980
THE EFFECT OF INCREASING DOSES OF INGESTED GLUCOSE ON INSULIN AND GASTRIC INHIBITORY POLYPEPTIDE (GIP) CONCENTRATIONS IN MAN
JM Falko, SE Crockett, S Cataland, TM O'dorisio, W Kramer, EL Mazzaferri
Clinical Endocrinology 1980
Invited commentary
PJ Kozinn
World Journal of Surgery 1980
The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man
E Ferrannini, J Wahren, P Felig, RA DeFronzo
Metabolism 1980
Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy man
PR Bratusch-Marrain, WK Waldhäusl, S Gasić, A Korn, P Nowotny
Metabolism 1980
Cholecystokinin and gastric inhibitory polypeptide not glucagonotropic in dogs
KR Sirinek, BA Levine, SE Crockett, S Cataland
Journal of Surgical Research 1980
Therapy of insulin-independent diabetes mellitus: General considerations
HE Lebovitz, MN Feinglos
Metabolism 1980
Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man
KB Lauritsen, AJ Moody, KC Christensen, SL Jensen
Scandinavian Journal of Gastroenterology 1980
Secretory effects of gastrins on isolated perfused porcine pancreas
SL Jensen, JF Rehfeld, JJ Holst, J Fahrenkrug, OV Nielsen, OB de Muckadell
American journal of physiology. Endocrinology and metabolism 1980
Augmentation of Insulin Secretion by a Non-Nutrient Drink
NJ Goldberg, TD Wingert, SR Levin, RI Adachi
Gastroenterology 1980
The Entero-insular Axis and the Metabolic Effects of Gastro-enteropancreatic Polypeptides
J Dupré
1980
Gastric Inhibitory Polypeptide
R Ebert, W Creutzfeldt
1980
Heterogeneity of plasma IRI responses in patients with IGT
K Kosaka, Y Akanuma
Diabetologia 1980
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
R DeFronzo, D Deibert, R Hendler, P Felig, V Soman
Journal of Clinical Investigation 1979
The incretin concept today
W Creutzfeldt
Diabetologia 1979
Evidence for a regulatory role of the stomach in islet cell function
V Schusdziarra, D Rouiller, RH Unger
Life Sciences 1979
Diabetes, blood lipids, lipoproteins, and change of environment: Restudy of the “new immigrant Yemenites” in Israel
AM Cohen, J Fidel, B Cohen, A Furst, S Eisenberg
Metabolism 1979
Evaluation of insulin secretory capacity in diabetes mellitus
DL Horwitz, AH Rubenstein
Human Pathology 1979
8 GIP and the entero-insular axis
JC Brown, SC Otte
Clinics in Endocrinology and Metabolism 1979
Early insulin release following suckling in neonatal lambs and rabbits
RJ Porter, JM Bassett
Diabetologia 1979
Increased glucose disposal after jejuno-ileostomy
JF Rehfeld, KB Lauritsen, JJ Holst
Diabetologia 1979
Clinical studies with gastric inhibitory polypeptide
JC Brown, S Otte
World Journal of Surgery 1979
Chirurgisches Forum ’79
F Linder, HD Röher, U Mittmann
1979
Oral Glucose Augmentation of Insulin Secretion INTERACTIONS OF GASTRIC INHIBITORY POLYPEPTIDE WITH AMBIENT GLUCOSE AND INSULIN LEVELS
DK Andersen, D Elahi, JC Brown, JD Tobin, R Andres
Journal of Clinical Investigation 1978
I.V. Glucose tolerance test: Correlation between FFA, glucose and IRI in normal, obese and diabetic subjects
R Prando, R Cordera, A Micheli, M Maiello, P Odetti, G Viviani, L Corsi, L Adezati
Acta Diabetologica Latina 1978
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects
R Prando, R Cordera, P Odetti, A Micheli, M Maiello, G Viviani, L Adezati
Acta Diabetologica Latina 1978
Duplication of the blood glucose curve of an OGTT in dogs by a prospectively programmed I.V. infusion: Infusion pattern and IRI response
U Fischer, EJ Freyse, E Salzsieder, G Albrecht
Acta Diabetologica Latina 1978
LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES
R Defronzo, J Wahren, E Ferrannini, P Felig
The Lancet 1978
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange
RA DeFronzo, E Ferrannini, R Hendler, J Wahren, P Felig
Proceedings of the National Academy of Sciences 1978
Myosins of secretory tissues
RE Ostlund, JT Leung, DM Kipnis
The Journal of Cell Biology 1978
Initial splanchnic extraction of ingested glucose in normal man
J Radziuk, TJ McDonald, D Rubenstein, J Dupre
Metabolism 1978
Pathogenesis of glucose intolerance in uremia
RA DeFronzo
Metabolism 1978
Blood insulin responses to blood glucose levels in high output sepsis and septic shock
GH Clowes, H Martin, S Walji, E Hirsch, R Gazitua, R Goodfellow
The American Journal of Surgery 1978
Temporal characteristics of insulin: Glucose ratio after varying degrees of stress and trauma in man
MM Meguid, F Aun, JS Soeldner
Journal of Surgical Research 1978
Relationship between two stages of prandial insulin release in rats
J Louis-Sylvestre
American journal of physiology. Endocrinology and metabolism 1978
Secretory effects of secretin on isolated perfused porcine pancreas
SL Jensen, J Fahrenkrug, JJ Holst, C Kühl, OV Nielsen, OB de Muckadell
American journal of physiology. Endocrinology and metabolism 1978
Diminished gastrointestinal potentiation of insulin secretion in human pregnancy
P Hornnes, C Khl, JG Klebe
Diabetologia 1978
Klinik der inneren Sekretion
A Labhart
1978
Dynamics of insulin secretion in dogs with alloxan diabetes
LN Dagaeva, FS Belikova, OI Podotykina, AV Makarova
Bulletin of Experimental Biology and Medicine 1978
Effect of secretin on basal- and glucose-stimulated insulin secretion in man.
Fahrenkrug J, Schaffalitzky de Muckadell OB, Kühl C
Diabetologia 1978
DIABETES: THE QUEST FOR BASAL NORMOGLYCÆMIA
RR Holman, RC Turner
The Lancet 1977
Pancreatic alpha and beta cell functions in cystic fibrosis
BM Lippe, MA Sperling, RR Dooley
The Journal of Pediatrics 1977
Normalization of Insulin Delivery to Diabetics by Pulsed Insulin Infusion
P Martin, S Genuth
IEEE Transactions on Biomedical Engineering 1977
Lack of gastrointestinal enhancement of the insulin response to glucose in newborn infants
KC King, R Schwartz, K Yamaguchi, PA Adam
The Journal of Pediatrics 1977
The Chemical Senses and Nutrition
WI DeWYS
The Chemical Senses and Nutrition 1977
A nonlinear model of the carbohydrate metabolism regulation system for oral and intravenous glucose tolerance test
C Cobelli, G Federspil, G Pacini, A salvan, C Scandellari
IFAC Proceedings Volumes 1977
Glucose control of basal insulin secretion in diabetes
ST McCarthy, E Harris, RC Turner
Diabetologia 1977
Extrapancreatic and pancreatic actions of glibenclamide in rats
W Heptner, A Zermatten, , O Christ,
Diabetologia 1977
Diabetes mellitus • B
R Beckmann, M Berger, A Beringer, P Berchtold, J Beyer, A Bischoff, G Brehm, BF Clarke, GR Constam, LJ Duncan, FA Gries, A Hasselblatt, R Hild, K Irmscher, K Jahnke, J Kühnau, H Liebermeister, K Lundbaek, G Meyer-Schwickerath, S Napp-Mellinghoff, M Neubauer, F Nobbe, K Oberdisse, P Petrides, R Petzoldt, H Sauer, K Schöffling, M Spitznas, J Steinke, M Vogel, KH Vogelberg, A Wessing
1977
Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia
JF Rehfeld
Journal of Clinical Investigation 1976
7Carbohydrate metabolism in liver disease
DG Johnston, KG Alberti
Clinics in Endocrinology and Metabolism 1976
1Carbohydrate metabolism in vivo: Regulation of the blood glucose level
EA Newsholme
Clinics in Endocrinology and Metabolism 1976
The Year in Metabolism 1975–1976
N Freinkel
1976
The enteral insulin-stimulation after pancreas transplantation in the pig
SL Jensen, OV Nielsen, C Khl
Diabetologia 1976
Glucagon, insulin and growth hormone response in obese women
F Fallucca, G Menzinger, S Gambardella, S Tamburrano, D Andreani
Acta Diabetologica Latina 1975
Aktuelle Ansichten über die Fettsuchtpathologie
A Bučko
Food / Nahrung 1975
The Glucose-Induced Gastrointestinal Stimulation of Insulin Secretion in Man: Relation to Age and to Gastrin Release
JF Rehfeld, F Stadil
European Journal of Clinical Investigation 1975
Effects of portacaval anastomosis on glucose tolerance in the dog: Evidence of an interaction between the gut and the liver in oral glucose disposal
HL Lickley, DJ Chisholm, A Rabinovitch, M Wexler, J Dupre
Metabolism 1975
Glucose consumption by red cells of diabetic patients and normal subjects. Effect of ethanol
GB Phillips, PB Mendershausen
Clinica Chimica Acta 1975
Diabetic glomerulosclerosis without glucose intolerance
DA Nash, PW Rogers, PC Langlinais, SM Bunn
The American Journal of Medicine 1975
Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects
J McMonagle, P Felig
Metabolism 1975
Proceedings of the 1974 Laurentian Hormone Conference
H Valtin, HW Sokol, D Sunde
Proceedings of the 1974 Laurentian Hormone Conference 1975
Physiology of Diabetes
NK Maclaren, M Cornblath
Pediatric Annals 1975
Diabetes mellitus · A
E Cerasi, P Dieterle, H Ege, A Englhardt, H Frerichs, W Gepts, A Hasselblatt, HR Henrichs, L Herberg, JJ Hoet, H Hungerland, K Jahnke, RJ Jarrett, G Jörgensen, KH Jørgensen, H Kasemir, H Keen, L Kerp, V Leclercq-Meyer, H Liebermeister, G Löffler, R Luft, WJ Malaisse, J Markussen, M Möllering, H Schadewaldt, J Schlichtkrull, K Schöffling, U Schwedes, PC Scriba, F Sundby, KH Usadel, L Weiss, H Zimmermann, K Oberdisse
1975
The enteral insulin-stimulation after whipple's operation
JF Rehfeld, F Stadil, H Baden, K Fischerman
Diabetologia 1975
Cholinergic Modification of Glucose-Induced Biphasic Insulin Release in Vitro
R Sharp, S Culbert, J Cook, A Jennings, IM Burr
Journal of Clinical Investigation 1974
THE RELATION BETWEEN A LARGE BABY AT BIRTH AND DIMINISHED MATERNAL FIRST PHASE INSULIN RESPONSE TO GLUCOSE
RS Ledward, PJ Paterson, RC Turner
BJOG: An International Journal of Obstetrics and Gynaecology 1974
Carbohydrate tolerance and insulin responses in obstructive jaundice
NG Soler, PD Exon, A Paton
British medical journal 1974
A radioimmunoassay for plasma insulin using zirconyl phosphate gel
JW Coffey, CF Nagy, R Lenusky, HJ Hansen
Biochemical Medicine 1974
The Biology of Alcoholism
B Kissin, H Begleiter
1974
Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range
K Kosaka, R Hagura, T Kuzuya, N Kuzuya
Diabetologia 1974
Candidate Hormones of the Gut
MI Grossman
Gastroenterology 1974
The Different Effects on the Serum Lipids and Fecal Steroids of High Carbohydrate Diets Given Orally or Intravenously
L DenBesten, RH Reyna, WE Connor, LD Stegink
Journal of Clinical Investigation 1973
The Effect of Gastrin on Basal- and Glucose-Stimulated Insulin Secretion in Man
JF Rehfeld, F Stadil
Journal of Clinical Investigation 1973
Insulin Sensitivity of Forearm Tissues in Prediabetic Man
T Pozefsky, MR Santis, JS Soeldner, RG Tancredi
Journal of Clinical Investigation 1973
THE SPECTRUM OF PLASMA INSULIN RESPONSES IN MIDDLE-AGED AND OLD NON-OBESE DIABETICS WITH VARIOUS DEGREES OF METABOLIC DERANGEMENT
K Johansen
Acta Medica Scandinavica 1973
Physical Training in Human Obesity II. Effects on Plasma Insulin in Glucose-Intolerant Subjects without Marked Hyperinsulinemia
P Björntorp, K Jounge, L Sjöström, L Sullivan
Scandinavian Journal of Clinical & Laboratory Investigation 1973
Coronary Heart Disease in Young Men: A Study of Seventy Patients with a Critical Review of Etiological Factors*
RB Blacket, B Leelarthaepin, AJ Palmer, JM Woodhill
Australian and New Zealand Journal of Medicine 1973
The role of carbohydrate and oral agents in the treatment of diabetes mellitus
WD Odell
California medicine 1973
Portal diversion for the treatment of glycogen storage disease in humans
TE Starzl, CW Putnam, KA Porter, CG Halgrimson, J Corman, BI Brown, RW Gotlin, DO Rodgerson, HL Greene
Annals of Surgery 1973
Alimentary hypoglycemia associated with the Zollinger-Ellison syndrome
TK O'Brien, G Tijtgat, JW Ensinck
The American Journal of Medicine 1973
Disassociation of the plasma insulin response from the blood glucose concentration during glucose infusions in normal dogs
J Olefsky, T Batchelder, JW Farquhar, GM Reaven
Metabolism 1973
Carbohydrate Metabolism and Acute Myocardial Infarction: Circulating Glucose, Insulin, Cortisol and Growth Hormone Responses and Excretion of Catecholamines
TL Kurt, E Genton, C Chidsey, P Beck, KE Sussman
Chest 1973
Neunundsiebzigster Kongress: Gehalten zu Wiesbaden vom 29. April – 3. Mai 1973
K Miehlke
1973
Aktuelle Ernährungswissenschaftliche Probleme
KH Bässler, G Siebert
1973
Suppressive effect of secretin upon pancreatic alpha cell function
F Santeusanio, GR Faloona, RH Unger
Journal of Clinical Investigation 1972
Energy metabolism and electrolytes during thiopentone meperidine anaesthesia in normal man
EA Moffitt, AD Sessler, RS Goldsmith, RJ Ryan, K Rehder
Canadian Anaesthetists’ Society Journal 1972
INSULIN SECRETION AFTER TOLBUTAMIDE AND AFTER SECRETIN IN PATIENTS WITH PANCREATIC DISEASES
T Deckert, K Kølendorf, I Persson, H Worning
Acta Medica Scandinavica 1972
The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels
CD Holdsworth, L Nye, E King
Gut 1972
Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection
S Wapnick, JJ Jones
Gut 1972
Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus
F Stephan, P Reville, R Thierry, JL Schlienger
Diabetologia 1972
Insulin secretion and body composition in obesity
AZ El-Khodary, MF Ball, IM Oweiss, JJ Canary
Metabolism 1972
Gastrointestinal Hormones and Insulin Secretion
JF Rehfeld
Scandinavian Journal of Gastroenterology 1972
Effect of exogenous estrogen on carbohydrate metabolism in postmenopausal women
LN Ajabor, CC Tsai, P Vela, SS Yen
American Journal of Obstetrics and Gynecology 1972
Insulin secretion in obesity after exercise
M Fahln, J Stenberg, P Bjrntorp
Diabetologia 1972
Gastric Operations and Glucose Homeostasis
RI Breuer, H Moses, TC Hagen, L Zuckerman
Gastroenterology 1972
Insulin Insensitivity of Large Fat Cells
JN Livingston, P Cuatrecasas, DH Lockwood
Science 1972
The Mechanism of insulin secretion after oral glucose administration: I. Multiphasic course of insulin mobilization after oral administration of glucose in conscious dogs. Differences to the behaviour after intravenous administration
U Fischer, H Hommel, M Ziegler, R Michael
Diabetologia 1972
Analytical review: The pathogenesis of diabetes mellitus and its relationship to biological aging
S Goldstein
Human Genetics 1971
Insulinmobilisierung beim Hund durch Scheinfütterung mit Glukose
U Fischer, H Hommel
Experientia 1971
Cirrhosis and diabetes
HO Conn, W Schreiber, SG Elkington
The American Journal of Digestive Diseases 1971
The Glucose Uptake of Human Adipose Tissue in Obesity
P Bjöentorp, P Berchtold, J Holm, B Larsson
European Journal of Clinical Investigation 1971
ON THE ROLE OF CYCLIC AMP IN INSULIN RELEASE: II. DYNAMIC ASPECTS AND RELATIONS TO ADRENERGIC RECEPTORS IN THE PERIFUSED PANCREAS OF ADULT RATS*
IM Burr, HP Taft, W Stauffacher, AE Renold
Annals of the New York Academy of Sciences 1971
Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group
GE Rosselin, JR Claude, EP Eschwege, E Patois, JM Warnet, JL Richard
Diabetologia 1971
A CONTROLLED STUDY OF PERORAL GLUCOSE, INSULIN AND POTASSIUM TREATMENT IN MYOCARDIAL INFARCTION
I Hjermann
Acta Medica Scandinavica 1971
Changes in plasma insulin related to the type of dietary carbohydrate in overweight hyperlipidemic male patients
NW Rodger, BP Squires, EL Du
Canadian Medical Association journal 1971
Determinants of insulin response to glucose absorption from human small bowel
AL Blum, WG Linscheer
Metabolism 1971
Effect of feeding on intravenous glucose tolerance and insulin response in piglets during the first day of life
J Gentz, B Persson, M Kellum, G Bengtsson, J Thorell
Life Sciences 1971
Effect of Diet Composition on the Hyperinsulinemia of Obesity
N Grey, DM Kipnis
New England Journal of Medicine 1971
Studies of Chlormadinone Acetate and Mestranol on Blood Glucose and Plasma Insulin. II. Twelfth Month Oral Glucose Tolerance Test**These studies were supported in part by funds from the Public Health Service, Consumer Protection and Environmental Health Service, Food and Drug Administration, and Department of Health, Education, and Welfare, under Contract CPF 69-32
WN Spellacy, WC Buhi, SA Birk, SA McCreary
Fertility and Sterility 1971
Adrenergic Modification of Glucose-Induced Biphasic Insulin Release from Perifused Rat Pancreas
IM Burr, L Balant, W Stauffacher, AE Renold
European Journal of Clinical Investigation 1971
The Pattern of Plasma Insulin Response to Glucose in Patients with a Previous Myocardial Infarction-The Respective Effects of Age and Disease
C Malherbe, M Gasparo, P Berthet, R Hertogh, JJ Hoet
European Journal of Clinical Investigation 1971
Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group: I. Relationship with plasma glucose, free fatty acids, cholesterol, triglycerides and corpulence
GE Rosselin, JR Claude, EP Eschwege, E Patois, JM Warnet, JL Richard
Diabetologia 1971
Cirrhosis and diabetes: II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis
HO Conn, W Schreiber, SG Elkington
The American Journal of Digestive Diseases 1971
The significance and interpretation of mildly abnormal oral glucose tolerance.
Alford FP, Martin FI, Pearson MJ
Diabetologia 1971
The gastrointestinal stimulus to insulin release II. A dual action of secretin
EW Kraegen, DJ Chisholm, JD Young, L Lazarus
Journal of Clinical Investigation 1970
The effect of fasting, diet, and actinomycin D on insulin secretion in the rat
NJ Grey, S Goldring, DM Kipnis
Journal of Clinical Investigation 1970
Perifusion of rat pancreatic tissue in vitro: substrate modification of theophylline-induced biphasic insulin release
IM Burr, L Balant, W Stauffacher, AE Renold
Journal of Clinical Investigation 1970
VIII—INSULIN AND GLUCOSE HOMŒOSTASIS
KJ Catt
The Lancet 1970
PLASMA-INSULIN AFTER TOLBUTAMIDE IN DIABETICS AND NON-DIABETICS
T Deckert, P Mogensen
Acta Medica Scandinavica 1970
Lessons of epidemiology of diabetes
RJ Jarrett
British medical journal 1970
Plasma triglyceride response to carbohydrates, fats and caloric intake
PJ Nestel, KF Carroll, N Havenstein
Metabolism 1970
The effect of physical training on insulin production in obesity
P Björntorp, K Jounge, L Sjöström, L Sullivan
Metabolism 1970
Early Diabetes
JM Stowers
Early Diabetes 1970
Effect of Gastrointestinal Hormones on Insulin and Glucagon Secretion
W Creutzfeldt, G Feurle, H Ketterer
New England Journal of Medicine 1970
Carbohydrate Homeostasis
R Levine, DE Haft
New England Journal of Medicine 1970
Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives
WN Spellacy, WC Buhi, CE Spellacy, LE Moses, JW Goldzieher
American Journal of Obstetrics and Gynecology 1970
The role of the portal circulation in glucose and fructose tolerance
N McIntyre, DS Turner, CD Holdsworth
Diabetologia 1970
The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects
JD Bigelow-Sherman, K Shima, EK Borden, R Penhallegon, PP Foà
Acta Diabetologica 1970
Les ripostes insulinémiques au glucose veineux et oral dans diverses formes de diabète sucré
J Mirouze, A Orsetti, H Lapinski
Acta Diabetologica 1970
Myocardial metabolism in open-heart surgery
EA Moffitt, JW Rosevear, GD Molnar, DC McGoon
The Journal of Thoracic and Cardiovascular Surgery 1970
STANDARDIZATION AND EVALUATION OF THE ORAL GLUCOSE TOLERANCE TEST
NG Carter, JH Maynard
The Medical Journal of Australia 1970
The Intestinal Insulinotropic Action after Jejuno-Ileostomy
JF Rehfeld, E Juhl, F Quaade
Scandinavian Journal of Gastroenterology 1970
Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man
J Dupre, JD Curtis, RH Unger, RW Waddell, JC Beck
Journal of Clinical Investigation 1969
The gastrointestinal stimulus to insulin release I. Secretin
DJ Chisholm, JD Young, L Lazarus
Journal of Clinical Investigation 1969
Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose
CJ Goodner, MJ Conway, JH Werbach
Journal of Clinical Investigation 1969
Diabetogenic action of streptozotocin: relationship of dose to metabolic response
A Junod, AE Lambert, W Stauffacher, AE Renold
Journal of Clinical Investigation 1969
Oral glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response
ME Abrams, RJ Jarrett, H Keen, DR Boyns, JN Crossley
British medical journal 1969
Type III hyperlipoproteinemia with low plasma thyroxine binding globulin
J Dyerberg
Metabolism 1969
Effects of various routes of caffeine administration on oral and intravenous glucose tolerance tests in dogs
OA DeCastro, H Sandberg, LJ Feinberg, S Bellet
Metabolism 1969
Fat cell function and insulin in a patient with generalized lipodystrophy
Boris, L Loridan
The Journal of Pediatrics 1969
Oral Glucose Tolerance Curve and Hypoglycemias in the Fed State
N Freinkel, BE Metzger
New England Journal of Medicine 1969
Insulin patterns prior to and after onset of diabetes
TS Danowski, YB Lombardo, LV Mendelsohn, DG Corredor, CR Morgan, G Sabeh
Metabolism 1969
Growth hormone and insulin levels in newly discovered glucose intolerance
G Sabeh, DG Corredor, LV Mendelsohn, CR Morgan, JC Sieracki, JH Sunder, JP Wingert, TS Danowski
Metabolism 1969
The diagnosis of diabetes mellitus
H Keen
Journal of clinical pathology. Supplement (Association of Clinical Pathologists) 1969
A Study of Carbohydrate Metabolism in Scleroderma**From the Sections of Dermatologyt and Endocrinology and Metabolism, Departmeot of Medicine, Hahnemann Medical College and Hospital, Philadelphia, Penna. 19102
R Fleischmajer, G Faludi
Journal of Investigative Dermatology 1969
A review of carbohydrate metabolism and the oral contraceptives
WN Spellacy
American Journal of Obstetrics and Gynecology 1969
The role of the liver in the disposal of orally administered 14C-glucose in the normal rat
SL Jeffcoate, AJ Moody
Diabetologia 1969
ALIMENTARY FACTORS IN THE ENDOCRINE RESPONSE TO ADMINISTRATION OF ARGININE IN MAN
J Dupré, JD Curtis, RW Waddell, JC Beck
The Lancet 1968
STRUCTURE OF THE VERVET-MONKEY-DISEASE AGENT
I Zlotnik, DI Simpson, DM Howard
The Lancet 1968
Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects
LJ Feinberg, H Sandberg, OD Castro, S Bellet
Metabolism 1968
Normal Growth with Subnormal Growth-Hormone Levels
LB Holmes, AG Frantz, MT Rabkin, JS Soeldner, JD Crawford
New England Journal of Medicine 1968
Advances in Metabolic Disorders
G Aurbach, JT Potts
Advances in Metabolic Disorders 1964
Insulin Resistance
A Voll, J Kloster
Acta Medica Scandinavica 1957

← Previous 1 2 3 … 26 27 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
On 2 videos
205 readers on Mendeley
1 readers on CiteULike
See more details